- Home
- VCEL vs NVRI Comparison
VCEL vs NVRI Comparison
Compare VCEL & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | NVRI |
|---|---|---|
| Founded | 1989 | 1853 |
| Country | United States | United States |
| Employees | N/A | 12000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | VCEL | NVRI |
|---|---|---|
| Price | $35.06 | $19.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $57.75 | N/A |
| AVG Volume (30 Days) | 702.1K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $276,259,000.00 | ★ $2,240,358,000.00 |
| Revenue This Year | $19.10 | $3.87 |
| Revenue Next Year | $17.95 | $3.70 |
| P/E Ratio | $110.64 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $5.71 |
| 52 Week High | $45.97 | $19.99 |
Technical Indicators
Market Signals| Indicator | VCEL | NVRI |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 57.64 |
| Support Level | $34.26 | $17.64 |
| Resistance Level | $38.48 | N/A |
| Average True Range (ATR) | 1.37 | 0.40 |
| MACD | 0.46 | 0.02 |
| Stochastic Oscillator | 94.67 | 68.14 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.